Biological Sciences - Articleposted 2024-10-30 02:05:08
Antibody-mediated co-delivery of programmable drug combinations
Xun Meng, Wenlong Sun, Weining Weng, Jing Shi, Boyang Ma, Kelly DeMarco, Fu Gui, and 5 more authors
Under Review
at
Articleposted 2024-10-15 11:02:46
Phase I First-in-Human Dose Escalation Study of the oral Casein Kinase 1α and Cyclin Dependent Kinase 7/9 inhibitor BTX-A51 in advanced MDS and AML
Brian Ball, Wenbin Xiao, Gautam Borthakur, Le Xuan Truong Nguyen, Melissa Valerio, Avanthika Venkatachalam, Guido Marcucci, and 9 more authors
Posted
at
Articleposted 2024-10-15 09:27:15
Therapeutic efficacy of galectin-1 inhibitor in treating malignant peripheral nerve sheath tumor
Tsung-Chieh Shih, Hsiao-Chi Wang, Keila Torres, Roger Xia, Marcio Malogolowkin, Ssu-Wei Hsu, Ching-Hsien Chen
Posted
at
Articleposted 2024-10-10 12:26:30
Inhibition of TFF3 Synergizes with c-MET Inhibitors to Decrease the CSC-like Phenotype and Metastatic Burden in ER+HER2+ Mammary Carcinoma
Peter Lobie, Chuyu He, Xuejuan Wang, Yi-Shiou Chiou, Basappa Basappa, tao Zhu, Vijay Pandey
Under Revision
at
Articleposted 2024-10-03 04:35:36
Ewing and Ewing-like-sarcoma tumoroid biobank reveals distinct drug sensitivities: translocation makes the difference
Hans Clevers, Femke Ringnalda, Gijs van Son, Laurens Verweij, Vicky Amo-Addae, Uta Flucke, Laura Hiemcke-Jiwa, and 13 more authors
Under Review
at
Articleposted 2024-09-26 06:57:33
The amino acid transporter SLC7A5 drives progression of PI3K-mutant intestinal cancer models and enhances response to MAPK-targeted therapy
Owen Sansom, Lucas Zeiger, Catriona Ford, Laura Millett, Valerie Meniel, Arafath Najumudeen, Kathryn Pennel, and 17 more authors
Under Review
at
Articleposted 2024-08-27 20:00:11
PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition
Sookhee Pae, Anna S Sedukhina, Runa Sugiyama, Sarah J Atanacio, Tatsuru Ohara, Masato Ishii, Kimino Minagawa, and 12 more authors
Under Revision
at
Articleposted 2024-08-26 18:00:38
Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell lines
Erdal Toprak, Fatma Neslihan Kalkan, M. Yildiz, N. Ezgi Wood, Michael Farid, Melissa McCoy, Milo Lin, and 3 more authors
Posted
at
Articleposted 2024-08-06 12:21:01
YY1 downregulation underlies therapeutic response to molecular targeted agents
Guanglei Zhuang, Shichao Zhou, Jingyu Zang, Meichun Cai, Kaiyan Ye, Jin Liu, Pengfei Ma, and 10 more authors
Under Revision
at
Articleposted 2024-07-25 11:03:20
In-vitro Expansion and Transduction of Primary Natural Killer Cells Using Feeder Cells Co-expressing Co-stimulatory Receptors and Membrane-bound IL-21
Thi Bao Tram TRAN, Thi Van Anh BUI, Thi Minh Thu TRAN, Minh Nguyen NGUYEN, Els VERHOEYEN, Thi Phuong Diem TRAN, Duc Minh Quan NGUYEN, and 5 more authors
Posted
at